A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia

[Japanese version of the Neuropsychiatric Inventory--a scoring system for neuropsychiatric disturbance in dementia patients].

Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · PubMed · Cited by 21,010 · see citing works

Special Care Units and Traditional Care in Dementia: Relationship with Behavior, Cognition, Functional Status and Quality of Life - A Review

Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589 · see citing works

The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia

Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568 · see citing works

Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria

Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1546 · Cited by 5,047 · see citing works

Primary Progressive Aphasia

Weıntraub, S. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530120075013 · Cited by 3,012 · see citing works

Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups.

(1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.4.416 · Cited by 1,331 · see citing works

The prevalence of frontotemporal dementia

Ratnavalli, E., Brayne, C., Dawson, K., & Hodges, J. R. (2002) · Neurology · doi:10.1212/wnl.58.11.1615 · Cited by 1,151 · see citing works

Cerebral Glucose Metabolism in Adults with Hyperactivity of Childhood Onset

Zametkin, A. J., NORDAHL, T. E., Gross, M., King, A. C., Semple, W. E., Rumsey, J. M., Hamburger, S., & Cohen, R. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011153232001 · Cited by 962 · see citing works

Pharmacological Treatment of Neuropsychiatric Symptoms of Dementia: A Review of the Evidence

Sink, K. M., Holden, K. F., & Yaffe, K. (2005) · JAMA · doi:10.1001/jama.293.5.596 · Cited by 910 · see citing works

Decreased β-Amyloid_1-42and Increased Tau Levels in Cerebrospinal Fluid of Patients With Alzheimer Disease

Sunderland, T., Linker, G., Mirza, N., Putnam, K. T., Friedman, D. L., Kimmel, L. H., Bergeson, J., Manetti, G. J., Zimmermann, M., Tang, B., et al. (2003) · JAMA · doi:10.1001/jama.289.16.2094 · Cited by 656 · see citing works

Is there a role for 5-HT1A agonists in the treatment of depression?

Blier, P., & Ward, N. M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01643-8 · Cited by 529 · see citing works

NEOCORTICAL CHOLINERGIC NEURONS IN ELDERLY PEOPLE

White, P., Goodhardt, M., Keet, J. P., Hiley, C. R., Carrasco, L. H., Williams, I. E. I., & Bowen, D. M. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92114-6 · Cited by 489 · see citing works

Widespread origin of the primate mesofrontal dopamine system.

Williams, S. M., & Goldman-Rakic, P. (1998) · Cerebral Cortex · doi:10.1093/cercor/8.4.321 · Cited by 481 · see citing works

Frontotemporal Dementia: A Randomised, Controlled Trial with Trazodone

Lebert, F., Stekke, W., Hasenbroekx, C., & Pasquier, F. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000077171 · Cited by 377 · see citing works

Pick’s Disease

Constantinidis, J., Richard, J., & Tissot, R. (2008) · European Neurology · doi:10.1159/000114320 · Cited by 352 · see citing works

Attention Deficit–Hyperactivity Disorder

Rappley, M. D. (2005) · New England Journal of Medicine · doi:10.1056/nejmcp032387 · Cited by 286 · see citing works

Neurotransmitters and Suicidal Behavior

Åsberg, M. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb52359.x · Cited by 286 · see citing works

Differential effect of a dopaminergic agonist on prefrontal function in traumatic brain injury patients

McDowell, S. (1998) · Brain · doi:10.1093/brain/121.6.1155 · Cited by 270 · see citing works

The American Psychiatric Publishing textbook of psychopharmacology

(2010) · Choice Reviews Online · doi:10.5860/choice.47-4164 · Cited by 233 · see citing works

Apathy: a treatable syndrome

Marin, R. S., Fogel, B. S., Hawkins, J. W., Duffy, J., & Krupp, B. H. (1995) · Journal of Neuropsychiatry · doi:10.1176/jnp.7.1.23 · Cited by 229 · see citing works

Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial

Rahman, S., Nestor, P. J., Hodges, J. R., Sahakian, B. J., & Deakin, J. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1686-5 · Cited by 217 · see citing works

Clinical and Physiological Consequences of Rapid Tryptophan Depletion

Moore, P. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00161-5 · Cited by 205 · see citing works

Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients

Bowen, D. M., Benton, J. S., Spillane, J. A., Smith, C., & Allen, S. J. (1982) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(82)90026-0 · Cited by 195 · see citing works

Frontotemporal Dementia: Paroxetine as a Possible Treatment of Behavior Symptoms

Moretti, R., Torre, P., Antonello, R. M., Cazzato, G., & Bava, A. (2002) · European Neurology · doi:10.1159/000067021 · Cited by 172 · see citing works

Glucose metabolism and serotonin receptors in the frontotemporal lobe degeneration

Franceschi, M., Anchisi, D., Pelati, O., Zuffi, M., Matarrese, M., Moresco, R. M., Fazio, F., & Perani, D. (2005) · Annals of Neurology · doi:10.1002/ana.20365 · Cited by 166 · see citing works

Equivalent Occupancy of Dopamine D₁ and D₂ Receptors With Clozapine: Differentiation From Other Atypical Antipsychotics

Tauscher, J., Hussain, T., Agid, O., Verhoeff, N. P. L. G., Wilson, A. A., Houle, S., Remington, G., Zipursky, R. B., & Kapur, S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.9.1620 · Cited by 159 · see citing works

Dietary Changes, Compulsions and Sexual Behavior in Frontotemporal Degeneration

Miller, B. L., Darby, A. L., Swartz, J. R., Yener, G., & Mena, I. G. (1995) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106946 · Cited by 158 · see citing works

Rivastigmine in Frontotemporal Dementia

Moretti, R., Torre, P., Antonello, R. M., Cattaruzza, T., Cazzato, G., & Bava, A. (2004) · Drugs & Aging · doi:10.2165/00002512-200421140-00003 · Cited by 157 · see citing works

Neurochemical enzyme changes in Alzheimer's and Pick's disease

Meier‐Ruge, W., Iwangoff, P., & Reichlmeier, K. (1984) · Archives of Gerontology and Geriatrics · doi:10.1016/0167-4943(84)90007-4 · Cited by 147 · see citing works

The organization of serotonergic projections to cerebral cortex in primates: Retrograde transport studies

Wilson, M. A., & Molliver, M. E. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90077-2 · Cited by 133 · see citing works

Methylphenidate (‘Ritalin’) can Ameliorate Abnormal Risk-Taking Behavior in the Frontal Variant of Frontotemporal Dementia

Rahman, S., Robbins, T. W., Hodges, J. R., Mehta, M. A., Nestor, P. J., Clark, L., & Sahakian, B. J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300886 · Cited by 131 · see citing works

The Distribution of Cerebral Muscarinic Acetylcholine Receptors In Vivo in Patients With Dementia

Weinberger, D. R. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530140061018 · Cited by 129 · see citing works

Basal nucleus of meynert

Tagliavini, F., & Pilleri, G. (1983) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(83)90203-4 · Cited by 128 · see citing works

Neurochemical Features of Frontotemporal Dementia

PROCTER, A. W., Qurne, M., & Francis, P. T. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051219 · Cited by 126 · see citing works

Theα 2 antagonist idazoxan remediates certain attentional and executive dysfunction in patients with dementia of frontal type

Coull, J. T., Sahakian, B. J., & Hodges, J. R. (1996) · Psychopharmacology · doi:10.1007/bf02246578 · Cited by 121 · see citing works

Mechanisms of antipsychotic-induced weight gain.

McIntyre, R. S., Mancini, D. A., & Basile, V. S. (2001) · PubMed · Cited by 119 · see citing works

Altered Serotonergic and Cholinergic Synaptic Markers in Pick's Disease

Sparks, D. L., & Markesbery, W. R. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530200032014 · Cited by 112 · see citing works

Striatal dopamine transporter and extrapyramidal symptoms in frontotemporal dementia

Rinne, J. O., Laine, M., Kaasinen, V., Norvasuo‐Heilä, M., Någren, K., & Helenius, H. Y. M. (2002) · Neurology · doi:10.1212/wnl.58.10.1489 · Cited by 109 · see citing works

Neurons and Their Dendrites in Frontotemporal Dementia

Ferrer, I. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051214 · Cited by 105 · see citing works

Efficacy of Fluvoxamine as a Treatment for Behavioral Symptoms in Frontotemporal Lobar Degeneration Patients

Ikeda, M., Shigenobu, K., Fukuhara, R., Hokoishi, K., Maki, N., Nebu, A., Komori, K., & Tanabe, H. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000076343 · Cited by 96 · see citing works

Olanzapine as a treatment of neuropsychiatric disorders of Alzheimer's disease and other dementias: A 24-month follow-up of 68 patients

Moretti, R., Torre, P., Antonello, R. M., Cazzato, G., Griggio, S., & Bava, A. (2003) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750301800410 · Cited by 94 · see citing works

Vulnerability to neuroleptic side effects in frontotemporal lobar degeneration

Pijnenburg, Y. A. L., Sampson, E. L., Harvey, R. J., Fox, N. C., & Rossor, M. N. (2002) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.774 · Cited by 91 · see citing works

Alterations in Brain Monoamine Oxidase Activity in Aging, Alzheimer's Disease, and Pick's Disease

Sparks, D. L., Woeltz, V. M., & Markesbery, W. R. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530190064017 · Cited by 89 · see citing works

Cortical Degeneration with Swollen Chromatolytic Neurons

Clark, A. W., Manz, H. J., White, C. L., Lehmann, J. C., Miller, D., & Coyle, J. T. (1986) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-198605000-00011 · Cited by 88 · see citing works

Frontotemporal dementia: evidence for impairment of ascending serotoninergic but not noradrenergic innervation

Yang, Y. M., & Schmitt, H. P. (2001) · Acta Neuropathologica · doi:10.1007/s004010000293 · Cited by 81 · see citing works

Decreased monoamine metabolites in frontotemporal dementia and Alzheimer’s disease

Sjögren, M. J. C., Minthon, L., Passant, U., Blennow, K., & Wallin, A. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00086-4 · Cited by 81 · see citing works

A post-mortem comparison of the cortical cholinergic system in Alzheimer's disease and Pick's disease

Wood, P. L., Etienne, P. E., Lal, S., Nair, N. P. V., Finlayson, M. H., Gauthier, S. G., Palo, J., Haltia, M., Paetau, A. E., & Bird, E. D. (1983) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(83)90200-9 · Cited by 79 · see citing works

The Klüver-Bucy Syndrome in Man; pp. 65–83

Pilleri, G. (2008) · Psychiatria et Neurologia · doi:10.1159/000128232 · Cited by 71 · see citing works

Goals in symptomatic pharmacologic management of frontotemporal lobar degeneration

Chow, T. W., & Mendez, M. F. (2002) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750201700504 · Cited by 71 · see citing works

Preliminary Neurochemical Findings in Non-Alzheimer Dementia due to Lobar Atrophy

Francis, P. T., Holmes, C. S., Webster, M.-T., Stratmann, G. C., PROCTER, A. W., & Bowen, D. M. (1993) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000107319 · Cited by 68 · see citing works

Neocortical morphometry and cholinergic neurochemistry in Pick's disease.

Hansen, L. A., DeTeresa, R. M., Tobias, H., Alford, M. F., & Terry, R. D. (1988) · PubMed Central · Cited by 64 · see citing works

Pick's disease (lobar sclerosis)

Uhl, G. R., Hilt, D. C., Hedreen, J. C., Whitehouse, P. J., & Price, D. L. (1983) · Neurology · doi:10.1212/wnl.33.11.1470 · Cited by 62 · see citing works

Case of Pick's Central Lobar Atrophy With Apparent Stabilization of Cognitive Decline After Treatment With Risperidone

Curtis, R., & Resch, D. S. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200006000-00018 · Cited by 59 · see citing works

Calbindin D-28k and parvalbumin immunoreactivity in the frontal cortex in patients with frontal lobe dementia of non-Alzheimer type associated with amyotrophic lateral sclerosis.

Ferrer, I., Tuñón, T., Serrano, M. T., Casas, R., Alcántara, S., Zujar, M. J., & Rivera, R. (1993) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.56.3.257 · Cited by 52 · see citing works

Neurochemical observations in a case of Pick's disease

Yates, C. M., Simpson, J. A., Maloney, A. F. J., & Gordon, A. (1980) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(80)90205-1 · Cited by 50 · see citing works

Neuroimaging studies of schizophrenia

Pfefferbaum, A., & Zipursky, R. B. (1991) · Schizophrenia Research · doi:10.1016/0920-9964(91)90033-n · Cited by 50 · see citing works

Quantitative Electroencephalography in Frontotemporal Dementia with Methylphenidate Response: A Case Study

Goforth, H. W., Konopka, L. M., Primeau, M., Ruth, A., O'Donnell, K., Patel, R., Poprawski, T. J., Shirazi, P. H., & Rao, M. S. (2004) · Clinical EEG and Neuroscience · doi:10.1177/155005940403500212 · Cited by 46 · see citing works

The Klüver-Bucy Syndrome in man. A clinico-anatomical contribution to the function of the medial temporal lobe structures.

Pilleri, G. (1966) · PubMed · Cited by 46 · see citing works

Effects of selegiline on fronto‐temporal dementia: a neuropsychological evaluation

Moretti, R., Torre, P., Antonello, R. M., Cazzato, G., & Bava, A. (2002) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.602 · Cited by 44 · see citing works

Frontotemporal dementia

KERTESZ, A. E., & Muñoz, D. G. (2002) · Medical Clinics of North America · doi:10.1016/s0025-7125(02)00011-1 · Cited by 43 · see citing works

Therapy and management of frontal lobe dementia patients

Litvan, I. (2001) · Neurology · doi:10.1212/wnl.56.suppl_4.s41 · Cited by 40 · see citing works

Efficacy of Cholinesterase Inhibitors in the Treatment of Neuropsychiatric Symptoms and Functional Impairment in Alzheimer Disease: A Meta-analysis

Trinh, N.-H., Hoblyn, J., Mohanty, S., & Yaffe, K. (2003) · JAMA · doi:10.1001/jama.289.2.210 · Cited by 37 · see citing works

Neurochemical and Histopathologic Alterations Characteristic of Pickʼs Disease in a Non-demented Individual

Sparks, D. L., Danner, F., Davis, D. G., Hackney, C., Landers, T. M., & Coyne, C. M. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199401000-00005 · Cited by 35 · see citing works

Studies on neurotransmitter markers of the basal ganglia in Pick's disease, with special reference to dopamine reduction

Kanazawa, I., Kwak, S., Sasaki, H., Muramoto, O., Mizutani, T., Hori, A., & Nukina, N. (1988) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(88)90020-2 · Cited by 35 · see citing works

Single photon emission computed tomography with [99Tc]-HM-PAO and [123I]-IBZM in Alzheimer's disease and dementia of frontal type: preliminary results

Frisoni, G. B., Pizzolato, G., Bianchetti, A., Chierichetti, F., Ferlin, G., Battistin, L., & Trabucchi, M. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1994.tb01661.x · Cited by 34 · see citing works

Imaging the serotonergic system in depression

D’Haenen, H. (2001) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf03035133 · Cited by 33 · see citing works

Evidence for an association between the CSF HVA:5-HIAA ratio and aggressiveness in frontotemporal dementia but not in Alzheimer's disease.

Engelborghs, S., Vloeberghs, E., Maertens, K., Marescau, B., & Deyn, P. P. D. (2004) · PubMed Central · Cited by 32 · see citing works

Efficacy of acetylcholinesterase inhibitors in frontotemporal dementia

Lampl, Y., Sadeh, M., & Lorberboym, M. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d445 · Cited by 30 · see citing works

Bromocriptine Treatment for Perseveration in Demented Patients

Imamura, T., Takanashi, M., Hattori, N., Fujimori, M., Yamashita, H., Ishii, K., & Yamadori, A. (1998) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199806000-00009 · Cited by 26 · see citing works

Functional Imaging, the Frontal Lobes, and Dementia

Friedland, R. P., Koss, E., Lerner, A. J., Hedera, P., Ellis, W. G., Dronkers, N. F., Ober, B. A., & Jagust, W. J. (1993) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000107323 · Cited by 26 · see citing works

Amantadine for Executive Dysfunction Syndrome in Patients With Dementia

Drayton, S. J., Davies, K., Steinberg, M., Leroi, I., Rosenblatt, A., & Lyketsos, C. G. (2004) · Psychosomatics · doi:10.1176/appi.psy.45.3.205 · Cited by 26 · see citing works

A juvenile case of frontotemporal dementia: Neurochemical and neuropathological investigations

Nagaoka, S., Arai, H., Iwamoto, N., Ohwada, J., Ichimiya, Y., Nakamura, M., & Inoue, R. (1995) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(95)00264-2 · Cited by 22 · see citing works

Dementia, Religion, and Spirituality

Stuckey, J. C., & Gwyther, L. P. (2003) · Dementia · doi:10.1177/14713012030023001 · Cited by 20 · see citing works

Long-Term Care of Patients with Frontotemporal Dementia

Merrilees, J. J., & Miller, B. L. (2003) · Journal of the American Medical Directors Association · doi:10.1016/s1525-8610(04)70408-9 · Cited by 16 · see citing works

Alterations of muscarinic acetylcholine receptors in atypical Pick's disease without Pick bodies

Odawara, T. (2003) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.7.965 · Cited by 15 · see citing works

Biological Correlates of Clinical Subgroups of Alzheimer’s Disease

Sjögren, M. J. C., Wikkelsø, C., Östling, S., Wallin, A., & Blennow, K. (2002) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000066025 · Cited by 14 · see citing works

Functional imaging, the frontal lobes, and dementia

Friedland, R. P. (1998) · Neurocase · doi:10.1093/neucas/4.1.7-a · Cited by 11 · see citing works

Double-blind, placebo-controlled study comparing effects of zopiclone and temazepam on cognitive functioning of insomniacs

Stip, É., Furlan, M., Lussier, I., Bourgouin, P. M., & Elie, R. (1999) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(199906)14:4 · Cited by 10 · see citing works

Lack of cholinergic deficit in the neocortex in pick's disease

Wood, P. L., Nair, N. P. V., Etienne, P. E., Lal, S., Gauthier, S. G., ROBITAILLE, Y., Bird, E. D., Palo, J., Haltia, M., & Paetau, A. E. (1983) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(83)90053-2 · Cited by 9 · see citing works

Evidence for an association between the CSFHVA : 5-HIAA ratio and aggressiveness in frontotemporal dementia but not in Alzheimer's disease

Engelborghs, S. (2004) · VUBIR (Vrije Universiteit Brussel) · Cited by 9 · see citing works

Long-Term Care of Patients With Frontotemporal Dementia

Merrilees, J. J., & Miller, B. L. (2003) · Journal of the American Medical Directors Association · doi:10.1097/01.jam.0000095366.91533.22 · Cited by 8 · see citing works

Alterations in Tyrosine Hydroxylase Immunoreactive Neurons of the Locus ceruleus in Pick's Disease

Luque, J. M., & Chan-Palay, V. C. (1991) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000107220 · Cited by 5 · see citing works

Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights substrates of disability

Sperfeld (1999) · Pure Amsterdam UMC · doi:10.1002/1531-8249(199911)46:5 · Cited by 2 · see citing works

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia

Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221 · see citing works

Dementia and Cognitive Impairment

Hugo, J., & Ganguli, M. (2014) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2014.04.001 · Cited by 916 · see citing works

Frontotemporal Lobar Degeneration

Rabinovici, G. D., & Miller, B. L. (2010) · CNS Drugs · doi:10.2165/11533100-000000000-00000 · Cited by 504 · see citing works

EFNS‐ENS Guidelines on the diagnosis and management of disorders associated with dementia

Sorbi, S., Hort, J., Erkinjuntti, T., Fladby, T., Gainotti, G., Gurvit, H. I., Nacmias, B., Pasquier, F., Popescu, B. O., Rektorová, I., et al. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2012.03784.x · Cited by 310 · see citing works

Monoaminergic neuropathology in Alzheimer’s disease

Šimić, G., Leko, M. B., Wray, S., Harrington, C. R., Delalle, I., Milošević, N. J., Bažadona, D., Buée, L., de Silva, R., Giovanni, G. D., et al. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.04.001 · Cited by 289 · see citing works

FTD and ALS: A Tale of Two Diseases

Ferrari, R., Kapogiannis, D., Huey, E. D., & Momeni, P. (2011) · Current Alzheimer Research · doi:10.2174/156720511795563700 · Cited by 270 · see citing works

Diagnostic Criteria for the Behavioral Variant of Frontotemporal Dementia (bvFTD): Current Limitations and Future Directions

Rascovsky, K., Hodges, J. R., Kipps, C., Johnson, J. K., Seeley, W. W., Mendez, M. F., Knopman, D. S., Kertesz, A., Mesulam, M. M., Salmon, D. P., et al. (2007) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31815c3445 · Cited by 256 · see citing works

Cognitive and affective Theory of Mind in neurodegenerative diseases: Neuropsychological, neuroanatomical and neurochemical levels

Poletti, M., Enrici, I., & Adenzato, M. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.07.004 · Cited by 258 · see citing works

Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial

Boxer, A. L., Knopman, D. S., Kaufer, D. I., Grossman, M., Onyike, C., Graf-Radford, N., Mendez, M., Kerwin, D., Lerner, A., Wu, C.-K., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70320-4 · Cited by 228 · see citing works

Neurotransmitter deficits from frontotemporal lobar degeneration

Murley, A. G., & Rowe, J. B. (2017) · Brain · doi:10.1093/brain/awx327 · Cited by 199 · see citing works

Alteration of behavioural phenotype in mice by targeted disruption of the progranulin gene

Kayasuga, Y., Chiba, S., Suzuki, M., Kikusui, T., Matsuwaki, T., Yamanouchi, K., Kotaki, H., Horai, R., Iwakura, Y., & Nishihara, M. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.07.020 · Cited by 189 · see citing works

Galantamine in Frontotemporal Dementia and Primary Progressive Aphasia

Kertesz, A., Morlog, D., Light, M., Blair, M., Davidson, W., Jesso, S., & Brashear, R. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000113034 · Cited by 217 · see citing works

Current approaches in the treatment of Alzheimer's disease

Shah, R. S., Lee, H., Zhu, X., Perry, G. L., Smith, M. A., & Castellani, R. J. (2008) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2008.02.005 · Cited by 176 · see citing works

Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders

Mundiñano, I.-C., Caballero, M. C., Ordóñez, C., Hernández, M., DiCaudo, C., Marcilla, I., Erro, M. E., Tuñon, M.-T., & Luquín, M. R. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0830-2 · Cited by 171 · see citing works

Towards a Unified Understanding of Lithium Action in Basic Biology and its Significance for Applied Biology

Jakobsson, E., Argüello‐Miranda, O., Chiu, S.-W., Fazal, Z., Kruczek, J., Núñez-Corrales, S., Pandit, S. A., & Pritchet, L. (2017) · The Journal of Membrane Biology · doi:10.1007/s00232-017-9998-2 · Cited by 158 · see citing works

An Evidence-Based Review of the Psychopathology of Frontotemporal Dementia: A Report of the ANPA Committee on Research

Mendez, M. F., Lauterbach, E. C., & Sampson, S. M. (2008) · Journal of Neuropsychiatry · doi:10.1176/jnp.2008.20.2.130 · Cited by 144 · see citing works

Frontotemporal Lobar Degeneration: Epidemiology, Pathology, Diagnosis and Management

Seltman, R. E., & Matthews, B. R. (2012) · CNS Drugs · doi:10.2165/11640070-000000000-00000 · Cited by 132 · see citing works

Serotonergic Function and Treatment of Behavioral and Psychological Symptoms of Frontotemporal Dementia

Herrmann, N., Black, S. E., Chow, T. W., Cappell, J., Tang‐Wai, D. F., & Lanctôt, K. L. (2011) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31823033f3 · Cited by 131 · see citing works

Development of disease-modifying drugs for frontotemporal dementia spectrum disorders

Panza, F., Lozupone, M., Seripa, D., Daniele, A., Watling, M., Giannelli, G., & Imbimbo, B. P. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0330-x · Cited by 122 · see citing works

Frontotemporal Dementia, Where Do We Stand? A Narrative Review

Antonioni, A., Raho, E. M., Lopriore, P., Pace, A. P., Latino, R. R., Assogna, M., Mancuso, M., Gragnaniello, D., Granieri, E., Pugliatti, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411732 · Cited by 133 · see citing works

An Open Label Study of Memantine Treatment in Three Subtypes of Frontotemporal Lobar Degeneration

Boxer, A., Lipton, A. M., Womack, K. B., Merrilees, J., Neuhaus, J., Pavlic, D., Gandhi, A. D., Red, D., Martin-Cook, K., Svetlik, D., et al. (2009) · Alzheimer Disease and Associated Disorders · doi:10.1097/wad.0b013e318197852f · Cited by 94 · see citing works

Diagnosis and Management of Behavioral Variant Frontotemporal Dementia

Pressman, P., & Miller, B. L. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.11.006 · Cited by 127 · see citing works

Selective serotonin reuptake inhibition modulates response inhibition in Parkinson’s disease

Ye, Z., Altena, E., Nombela, C., Housden, C. R., Maxwell, H., Rittman, T., Huddleston, C., Rae, C. L., Regenthal, R., Sahakian, B. J., et al. (2014) · Brain · doi:10.1093/brain/awu032 · Cited by 118 · see citing works

Frontotemporal lobar degeneration: current perspectives

Kurz, A., Riedl, L., Mackenzie, I. R., Förstl, H., & Diehl‐Schmid, J. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s38706 · Cited by 114 · see citing works

Frontotemporal Dementias: A Review

Weder, N. D., Aziz, R., Wilkins, K. M., & Tampi, R. R. (2007) · Annals of General Psychiatry · doi:10.1186/1744-859x-6-15 · Cited by 110 · see citing works

Dementia syndromes: evaluation and treatment

Scott, K. R., & Barrett, A. M. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.4.407 · Cited by 107 · see citing works

Eating Behaviors and Dietary Changes in Patients With Dementia

Cipriani, G., Carlesi, C., Lucetti, C., Danti, S., & Nuti, A. (2016) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317516673155 · Cited by 107 · see citing works

Human iPSC-derived neuronal model of Tau-A152T frontotemporal dementia reveals tau-mediated mechanisms of neuronal vulnerability

Silva, M. C., Cheng, C., Mair, W., Almeida, S., Fong, H., Biswas, M. H. U., Zhang, Z., Huang, Y., Temple, S., Coppola, G., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.08.001 · Cited by 103 · see citing works

Treatment of Frontotemporal Dementia

Tsai, R. M., & Boxer, A. (2014) · Current Treatment Options in Neurology · doi:10.1007/s11940-014-0319-0 · Cited by 104 · see citing works

GABA and glutamate deficits from frontotemporal lobar degeneration are associated with disinhibition

Murley, A. G., Rouse, M. A., Jones, P. S., Ye, R., Hezemans, F. H., O’Callaghan, C., Frangou, P., Kourtzi, Z., Rua, C., Carpenter, T. A., et al. (2020) · Brain · doi:10.1093/brain/awaa305 · Cited by 101 · see citing works

A 6‐month, open‐label study of memantine in patients with frontotemporal dementia

Diehl‐Schmid, J., Förstl, H., Perneczky, R., Pohl, C., & Kurz, A. (2008) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1973 · Cited by 96 · see citing works

Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options

Lamb, R., Rohrer, J. D., Lees, A. J., & Morris, H. R. (2016) · Current Treatment Options in Neurology · doi:10.1007/s11940-016-0422-5 · Cited by 95 · see citing works

The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia

Engelborghs, S., Vloeberghs, E., Bastard, N. L., Buggenhout, M. V., Mariën, P., Somers, N., Nagels, G., Pickut, B. A., & Deyn, P. P. D. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2007.10.018 · Cited by 95 · see citing works

Diagnosis and Management of Behavioral Issues in Frontotemporal Dementia

Manoochehri, M., & Huey, E. (2012) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-012-0302-7 · Cited by 89 · see citing works

Conceptualizing neuropsychiatric diseases with multimodal data-driven meta-analyses – The case of behavioral variant frontotemporal dementia

Schroeter, M. L., Laird, A. R., Chwiesko, C., Deuschl, C., Schneider, E., Bzdok, D., Eickhoff, S. B., & Neumann, J. (2014) · Cortex · doi:10.1016/j.cortex.2014.02.022 · Cited by 94 · see citing works

The Human Frontal Lobes and Frontal Network Systems: An Evolutionary, Clinical, and Treatment Perspective

Hoffmann, M. W. (2013) · ISRN Neurology · doi:10.1155/2013/892459 · Cited by 90 · see citing works

Improving response inhibition systems in frontotemporal dementia with citalopram

Hughes, L. E., Rittman, T., Regenthal, R., Robbins, T. W., & Rowe, J. B. (2015) · Brain · doi:10.1093/brain/awv133 · Cited by 94 · see citing works

Frontotemporal Dementia Treatment: Current Symptomatic Therapies and Implications of Recent Genetic, Biochemical, and Neuroimaging Studies

Boxer, A. L., & Boeve, B. F. (2007) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31815c345e · Cited by 88 · see citing works

Frontotemporal Dementia and Mania

Woolley, J. D., Wilson, M. R., Hung, E. K., Gorno-Tempini, M.-L., Miller, B. L., & Shim, J. J. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07061001 · Cited by 87 · see citing works

Frontotemporal Dementia: Therapeutic Interventions

Mendez, M. F. (2009) · Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences · doi:10.1159/000197896 · Cited by 84 · see citing works

A review of executive function deficits and pharmacological management in children and adolescents.

Hosenbocus, S., & Chahal, R. (2012) · Europe PMC (PubMed Central) · Cited by 84 · see citing works

Memantine for Behavioral Disturbances in Frontotemporal Dementia: A Case Series

Swanberg, M. (2007) · Alzheimer Disease and Associated Disorders · doi:10.1097/wad.0b013e318047df5d · Cited by 72 · see citing works

Toward a glutamate hypothesis of frontotemporal dementia

Benussi, A., Alberici, A., Buratti, E., Ghidoni, R., Gardoni, F., Di Luca, M., Padovani, A., & Borroni, B. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00304 · Cited by 90 · see citing works

Psychosis in Frontotemporal Dementia

Shinagawa, S., Nakajima, S., Plitman, E., Graff‐Guerrero, A., Mimura, M., Nakayama, K., & Miller, B. L. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140312 · Cited by 79 · see citing works

Dissociating behavioral disorders in early dementia—An FDG-PET study

Schroeter, M. L., Vogt, B., Frisch, S., Becker, G., Seese, A., Barthel, H., Mueller, K., Villringer, A., & Sabri, O. (2011) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2011.06.009 · Cited by 77 · see citing works

Cognitive and behavioral challenges in caring for patients with frontotemporal dementia and amyotrophic lateral sclerosis

Merrilees, J. J., Klapper, J., Murphy, J. M., Lomen, C. E., & Miller, B. L. (2010) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482961003605788 · Cited by 76 · see citing works

Low-dose Lithium Treatment for Agitation and Psychosis in Alzheimer Disease and Frontotemporal Dementia

Devanand, D. P., Pelton, G. H., D’Antonio, K., Strickler, J. G., Kreisl, W. C., Noble, J. M., Marder, K. S., Skomorowsky, A., & Huey, E. D. (2016) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000161 · Cited by 73 · see citing works

Frontotemporal Dementia

Younes, K., & Miller, B. L. (2020) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2020.02.006 · Cited by 74 · see citing works

Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy

Bowen, D. M., PROCTER, A. W., Mann, D. M. A., Snowden, J. S., Esiri, M. M., Neary, D., & Francis, P. T. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0992-8 · Cited by 73 · see citing works

Mechanisms of Granulin Deficiency: Lessons from Cellular and Animal Models

Kleinberger, G., Capell, A., Haass, C., & Broeckhoven, C. V. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8380-8 · Cited by 72 · see citing works

Closed-Loop Implantable Therapeutic Neuromodulation Systems Based on Neurochemical Monitoring

Mirza, K. B., Golden, C. T., Nikolić, K., & Toumazou, C. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00808 · Cited by 70 · see citing works

Modifiable Factors Related to Abusive Behaviors in Nursing Home Residents With Dementia

Volicer, L., van der Steen, J. T., & Frijters, D. H. M. (2009) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2009.06.004 · Cited by 69 · see citing works

Characteristics and progression of patients with frontotemporal dementia in a regional memory clinic network

Leroy, M., Bertoux, M., Skrobala, E., Mode, E., Adnet‐Bonte, C., Ber, I. L., Bombois, S., Cassagnaud, P., Chen, Y. S., Deramecourt, V., et al. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00753-9 · Cited by 68 · see citing works

Frontotemporal dementia and primary progressive aphasia, a review

Kirshner, H. S. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s38821 · Cited by 71 · see citing works

The Impact of Neurodegeneration on Network Connectivity: A Study of Change Detection in Frontotemporal Dementia

Hughes, L. E., & Rowe, J. B. (2013) · Journal of Cognitive Neuroscience · doi:10.1162/jocn_a_00356 · Cited by 63 · see citing works

New approaches to the treatment of frontotemporal lobar degeneration

Vossel, K. A., & Miller, B. L. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328318444d · Cited by 66 · see citing works

Platelet Serotonin Level Predicts Survival in Amyotrophic Lateral Sclerosis

Dupuis, L., Spreux‐Varoquaux, O., Bensimon, G., Jullien, P., Lacomblez, L., Salachas, F., Bruneteau, G., Pradat, P., Loeffler, J., & Meininger, V. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013346 · Cited by 65 · see citing works

Stimulant Treatment of Frontotemporal Dementia in 8 Patients

Huey, E. D., Garcia, C., Wassermann, E. M., Tierny, M. C., & Grafman, J. H. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n1219a · Cited by 65 · see citing works

Secondary Bipolar Disorder and Diogenes Syndrome in Frontotemporal Dementia

Gálvez-Andres, A., Blasco-Fontecilla, H., ́lez-Parra, S. G., Molina, J. D. D., Padín, J. M., & Rodríguez, R. H. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31815a57c1 · Cited by 65 · see citing works

Hallucinations in Neurodegenerative Diseases

Burghaus, L., Eggers, C., Timmermann, L., Fink, G. R., & Diederich, N. J. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2011.00247.x · Cited by 65 · see citing works

Clinical course of neuropathologically confirmed frontal-variant Alzheimer's disease

Taylor, K. I., Probst, A., Miserez, A. R., Monsch, A. U., & Tolnay, M. (2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0746 · Cited by 65 · see citing works

Psychedelic‐inspired approaches for treating neurodegenerative disorders

Saeger, H. N., & Olson, D. E. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15544 · Cited by 65 · see citing works

Neurophysiological signatures of Alzheimer’s disease and frontotemporal lobar degeneration: pathology versus phenotype

Sami, S. A. K., Williams, N., Hughes, L. E., Cope, T., Rittman, T., Coyle-Gilchrist, I. T. S., Henson, R. N., & Rowe, J. B. (2018) · Brain · doi:10.1093/brain/awy180 · Cited by 61 · see citing works

Sex is a defining feature of neuroimaging phenotypes in major brain disorders

Salminen, L. E., Tubi, M., Bright, J. K., Thomopoulos, S., Wieand, A., & Thompson, P. (2020) · Human Brain Mapping · doi:10.1002/hbm.25438 · Cited by 58 · see citing works

Antidepressant medications in dementia: evidence and potential mechanisms of treatment-resistance

Costello, H., Roiser, J. P., & Howard, R. (2023) · Psychological Medicine · doi:10.1017/s003329172200397x · Cited by 60 · see citing works

Reorganisation of brain networks in frontotemporal dementia and progressive supranuclear palsy

Hughes, L. E., Ghosh, B. C. P., & Rowe, J. B. (2013) · NeuroImage: Clinical · doi:10.1016/j.nicl.2013.03.009 · Cited by 60 · see citing works

Cognition and Amyotrophic Lateral Sclerosis (ALS)

Irwin, D. J., Lippa, C. F., & Swearer, J. M. (2007) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317507301613 · Cited by 60 · see citing works

A Model for Management of Behavioral Symptoms in Frontotemporal Lobar Degeneration

Merrilees, J. J. (2007) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31815bf774 · Cited by 59 · see citing works

Use of Psychostimulants in Patients with Dementia

Dolder, C. R., Davis, L. N., & McKinsey, J. (2010) · Annals of Pharmacotherapy · doi:10.1345/aph.1p341 · Cited by 57 · see citing works

Off-Label Medication Use in Frontotemporal Dementia

Hu, B., Ross, L., Neuhaus, J., Knopman, D., Kramer, J., Boeve, B., Caselli, R., Graff-Radford, N., Mendez, M., Miller, B., et al. (2010) · American Journal of Alzheimers Disease & Other Dementias · doi:10.1177/1533317509356692 · Cited by 61 · see citing works

Cognitive and behavioural inhibition deficits in neurodegenerative dementias

Migliaccio, R., Tanguy, D., Bouzigues, A., Sezer, I., Dubois, B., Ber, I. L., Batrancourt, B., Godefroy, V., & Lévy, R. (2020) · Cortex; a journal devoted to the study of the nervous system and behavior · doi:10.1016/j.cortex.2020.08.001 · Cited by 48 · see citing works

Abhorring the vacuum: use of Alzheimer’s disease medications in frontotemporal dementia

Kerchner, G. A., Tartaglia, M. C., & Boxer, A. L. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.6 · Cited by 56 · see citing works

Theoretical exploration of the neural bases of behavioural disinhibition, apathy and executive dysfunction in preclinical Alzheimer's disease in people with Down's syndrome: potential involvement of multiple frontal‐subcortical neuronal circuits

Ball, S. L., Holland, A. J., Watson, P., & Huppert, F. A. (2010) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2010.01261.x · Cited by 53 · see citing works

The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: The next therapeutic frontier)

Boxer, A. L., Gold, M., Huey, E. D., Hu, W. T., Rosen, H. J., Kramer, J. H., Gao, F., Burton, E. A., Chow, T. W., Kao, A. W., et al. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.03.003 · Cited by 54 · see citing works

Agomelatine Improves Apathy in Frontotemporal Dementia

Callegari, I., Mattei, C., Benassi, F., Krüeger, F., Grafman, J. H., Yaldizli, Ö., Sassos, D., Massucco, D., Scialò, C., Nobili, F. M., et al. (2016) · Neurodegenerative Diseases · doi:10.1159/000445873 · Cited by 54 · see citing works

Frontotemporal dementia: a review for primary care physicians.

Cardarelli, R., KERTESZ, A. E., & Knebl, J. A. (2010) · PubMed · Cited by 53 · see citing works

Clinical Subtypes of Frontotemporal Dementia

Ghosh, S., & Lippa, C. F. (2013) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317513494442 · Cited by 50 · see citing works

Cerebrospinal Fluid Aβ42 Levels: When Physiological Become Pathological State

Martorana, A., Lorenzo, F. D., Belli, L., Sancesario, G., Toniolo, S., Sallustio, F., Sancesario, G. M., & Koch, G. (2015) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12476 · Cited by 51 · see citing works

Brain Serotonergic and Noradrenergic Deficiencies in Behavioral Variant Frontotemporal Dementia Compared to Early-Onset Alzheimer’s Disease

Vermeiren, Y., Janssens, J., Aerts, T., Martin, J., Sieben, A., Dam, D. V., & Deyn, P. P. D. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160320 · Cited by 50 · see citing works

Managing Cognition in Progressive Supranuclear Palsy

Rittman, T., Coyle-Gilchrist, I. T. S., & Rowe, J. B. (2016) · Neurodegenerative Disease Management · doi:10.2217/nmt-2016-0027 · Cited by 50 · see citing works

Long-term follow-up in primary progressive aphasia: Clinical course and health care utilisation

Riedl, L., Last, D., Danek, A., & Diehl‐Schmid, J. (2014) · Aphasiology · doi:10.1080/02687038.2014.904497 · Cited by 49 · see citing works

Looking beneath the surface: the importance of subcortical structures in frontotemporal dementia

Bocchetta, M., Malpetti, M., Todd, E. G., Rowe, J. B., & Rohrer, J. D. (2021) · Brain Communications · doi:10.1093/braincomms/fcab158 · Cited by 49 · see citing works

Pharmacological Management of Apathy in Dementia

Azhar, L., Kusumo, R. W., Marotta, G., Lanctôt, K., & Herrmann, N. (2022) · CNS Drugs · doi:10.1007/s40263-021-00883-0 · Cited by 39 · see citing works

Serotonin 2A Receptors, Citalopram and Tryptophan-Depletion: a Multimodal Imaging Study of their Interactions During Response Inhibition

Macoveanu, J., Hornbøll, B., Elliott, R., Erritzøe, D., Paulson, O. B., Siebner, H. R., Knudsen, G. M., & Rowe, J. B. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.264 · Cited by 47 · see citing works

Constructing and characterizing a bioactive small molecule and microRNA association network for Alzheimer's disease

Meng, F., Dai, E., Yu, X., Zhang, Y., Chen, X., Liu, X., Wang, S., Wang, L., & Jiang, W. (2013) · Journal of The Royal Society Interface · doi:10.1098/rsif.2013.1057 · Cited by 47 · see citing works

Different apathy clinical profile and neural correlates in behavioral variant frontotemporal dementia and Alzheimer's disease

Fernández‐Matarrubia, M., Matías‐Guiu, J. A., Cabrera‐Martín, M. N., Moreno‐Ramos, T., Valles‐Salgado, M., Carreras, J. L., & Matías‐Guiu, J. (2017) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4695 · Cited by 45 · see citing works

The Neuropsychology (Broadly Conceived) of Multiple System Atrophy, Progressive Supranuclear Palsy, and Corticobasal Degeneration

Gerstenecker, A. (2017) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acx093 · Cited by 38 · see citing works

Pharmacological Treatments for Frontotemporal Dementias

Nardell, M., & Tampi, R. (2014) · American Journal of Alzheimers Disease & Other Dementias · doi:10.1177/1533317513507375 · Cited by 32 · see citing works

Use of Cholinesterase Inhibitors in Non-Alzheimer’s Dementias

Noufi, P. E., Khoury, R., Jeyakumar, S., & Grossberg, G. T. (2019) · Drugs & Aging · doi:10.1007/s40266-019-00685-6 · Cited by 44 · see citing works

Predicting loss of independence and mortality in frontotemporal lobar degeneration syndromes

Murley, A. G., Rouse, M. A., Coyle-Gilchrist, I. T. S., Jones, P. S., Li, W., Wiggins, J., Lansdall, C. J., Rodríguez, P. V., Wilcox, A., Patterson, K. E., et al. (2021) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-324903 · Cited by 44 · see citing works

Metabolic changes over the course of aging in a mouse model of tau deposition

Joly‐Amado, A., Serraneau, K. S., Brownlow, M. L., de Evsikova, C. M., Speakman, J. R., Gordon, M. N., & Morgan, D. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.04.013 · Cited by 43 · see citing works

Topiramate may Modulate Alcohol Abuse But not Other Compulsive Behaviors in Frontotemporal Dementia

Cruz, M. S., Marinho, V., Fontenelle, L. F., Engelhardt, E., & Laks, J. (2008) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0b013e31816bdf73 · Cited by 43 · see citing works

Cognitive-behavioral changes in amyotrophic lateral sclerosis: Screening prevalence and impact on patients and caregivers

Bock, M., Duong, Y.-N., Kim, A., Allen, I. E., Murphy, J. M., & Lomen, C. E. (2016) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2016.1165257 · Cited by 42 · see citing works

Frontotemporal dementia

Miller, B. L., & Guerra, J. J. L. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64012-3.00003-4 · Cited by 42 · see citing works

No effect of DC brain polarization on verbal fluency in patients with advanced frontotemporal dementia

Huey, E. D., Probasco, J. C., Moll, J., Stocking, J., Ko, M.-H., Grafman, J. H., & Wassermann, E. M. (2007) · Clinical Neurophysiology · doi:10.1016/j.clinph.2007.02.026 · Cited by 41 · see citing works

A new boronic acid based fluorescent reporter for catechol

Wu, Z., Li, M., Fang, H., & Wang, B. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.09.060 · Cited by 41 · see citing works

Treatment Options for Tauopathies

Karakaya, T., Fußer, F., Prvulovic, D., & Hampel, H. J. (2012) · Current Treatment Options in Neurology · doi:10.1007/s11940-012-0168-7 · Cited by 39 · see citing works

Coumarins: Auspicious Cholinesterase and Monoamine Oxidase Inhibitors

Orhan, İ. E., & Gülcan, H. O. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150427113103 · Cited by 39 · see citing works

A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias

Bolsewig, K., Hok-A-Hin, Y. S., Sepe, F. N., Boonkamp, L., Jacobs, D., Bellomo, G., Paoletti, F. P., Vanmechelen, E., Teunissen, C. E., Parnetti, L., et al. (2022) · Journal of Alzheimer's Disease · doi:10.3233/jad-220318 · Cited by 36 · see citing works

Comparison of polysomnographic variables and their relationship to cognitive impairment in patients with Alzheimer’s disease and frontotemporal dementia

Kundermann, B., Thum, A., Rocamora, R., Haag, A., Krieg, J.-C., & Hemmeter, U. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.07.008 · Cited by 38 · see citing works

Neurotransmitter Dysfunction and Neurotransmitter Replacement Therapy as Part of Frontotemporal Dementia Treatment

Vercelletto, M., Bourin, M., Lacomblez, L., Verpillat, P., & Derkinderen, P. (2005) · Current Psychiatry Reviews · doi:10.2174/157340005774575127 · Cited by 1 · see citing works

SEROTONERGIC DRUGS FOR MANAGEMENT OF BEHAVIOURAL SYMPTOMS OF FRONTOTEMPORAL DEMENTIA: A SYSTEMATIC REVIEW

Bhandari, N. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-311750.22

Frontotemporale Demenz: Neurotransmitter und klinische Symptomatik im Fokus therapeutischer Überlegungen

Lenz, B., Sidiropoulos, C., Bleich, S., & Kornhuber, J. (2009) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/s-0028-1109403 · Cited by 3 · see citing works

Pharmacological Management of Psychiatric Symptoms in Frontotemporal Dementia: A Systematic Review

Buoli, M., Serati, M., Caldiroli, A., Galimberti, D., Scarpini, E. A., & Altamura, A. C. (2017) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988717700506 · Cited by 27 · see citing works

Treatment approaches to symptoms associated with frontotemporal degeneration

Chow, T. W. (2005) · Current Psychiatry Reports · doi:10.1007/s11920-005-0040-5 · Cited by 28 · see citing works